[Complement consumption as criterion of the tolerogenicity of a globulin preparation].
Experiments on mice (296 animals) were made to study the capability of native and deaggregated preparations of human globulin to fix complement as well as the relationship of this indicator to tolerogenic properties of the preparations in question. Ultracentrifuged preparations were discovered to have the decreased capability to activate complement. As anticomplementary properties of the preparations become more demonstrable their tolerogenicity declines. The decreased capability to activate complement can be used as criterion in screening tolerogenic preparations.
D000818:Animals; D003169:Complement Inactivator Proteins / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology*; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000276:immunology*; D051379:Mice; D009930:Organic Chemicals
D003169:Complement Inactivator Proteins; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D009930:Organic Chemicals; C029248:Tolerogen; C012749:anticomplement; D003165:Complement System Proteins
Potreblenie komplementa kak kriteriĭ tolerantnosti globulinovogo preparata.